CT1194C
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CT1194C, covering 2025-07-16 to 2025-07-16. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma [Phase 1]